vimarsana.com
Home
Live Updates
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab : vimarsana.com
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab
In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4...
Related Keywords
Seoul ,
Soult Ukpyolsi ,
South Korea ,
Mannheim ,
Baden Wüberg ,
Germany ,
Ukraine ,
Russia ,
Texas ,
United States ,
Hye Ryun Kim ,
Mary Beth Sandin ,
Andreas Harstrick ,
Alexander Fudukidis ,
Artiva Allo ,
University Of Texas Md Anderson Cancer Center ,
Professor At Yonsei University College Of Medicine ,
Chief Medical ,
Chief Executive Officer ,
Yonsei University College ,
Cancer Center ,
vimarsana.com © 2020. All Rights Reserved.